Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Pilot study of a condensed communication skills workshop for gynecologic oncology fellows.

Urban RR, Fay EE, Podgurski L, Bevis K, Carey EC, Lefkowits C, Amory J.

Gynecol Oncol Rep. 2019 Aug 30;30:100492. doi: 10.1016/j.gore.2019.100492. eCollection 2019 Nov.

2.

Intraperitoneal ports placed at the time of bowel resection for treatment of ovarian cancer: Complications and surgical outcomes.

Kay AH, Urban RR, Gray HJ.

Gynecol Oncol. 2019 Nov;155(2):220-223. doi: 10.1016/j.ygyno.2019.08.020. Epub 2019 Sep 3.

PMID:
31488245
3.

Patterns and duration of primary and recurrent treatment in ovarian cancer patients with germline BRCA mutations.

Jorge S, Swisher EM, Norquist BM, Pennington KP, Gray HJ, Urban RR, Garcia RL, Doll KM.

Gynecol Oncol Rep. 2019 Aug 9;29:113-117. doi: 10.1016/j.gore.2019.08.001. eCollection 2019 Aug.

4.

Post-diagnosis use of antihypertensive medications and the risk of death from ovarian cancer.

Harding BN, Delaney JA, Urban RR, Weiss NS.

Gynecol Oncol. 2019 Aug;154(2):426-431. doi: 10.1016/j.ygyno.2019.05.030. Epub 2019 Jun 7.

PMID:
31178150
5.

Use of Statin Medications Following Diagnosis in Relation to Survival among Women with Ovarian Cancer.

Harding BN, Delaney JA, Urban RR, Weiss NS.

Cancer Epidemiol Biomarkers Prev. 2019 Jul;28(7):1127-1133. doi: 10.1158/1055-9965.EPI-18-1194. Epub 2019 May 7.

PMID:
31064757
6.

The perceptions of gynecologic oncology fellows on readiness for subspecialty training following OB/GYNRESIDENCY.

Urban RR, Ramzan AA, Doo DW, Sheeder J, Guntupalli SR.

Gynecol Oncol Rep. 2019 Mar 20;28:104-108. doi: 10.1016/j.gore.2019.03.007. eCollection 2019 May.

7.

Two cases of extragonadal malignant transformation of endometriosis after TAH/BSO for benign indications.

Eurich KE, Goff BA, Urban RR.

Gynecol Oncol Rep. 2019 Jan 4;28:23-25. doi: 10.1016/j.gore.2018.12.011. eCollection 2019 May.

8.

Revisiting Minimally Invasive Surgery in the Management of Early-Stage Cervical Cancer.

Pennington KP, Urban RR, Gray HJ.

J Natl Compr Canc Netw. 2019 Jan;17(1):86-90. doi: 10.6004/jnccn.2018.7263. Review.

PMID:
30659132
9.

Fellow Perceptions of Residency Training in Obstetrics and Gynecology.

Urban RR, Ramzan AA, Doo DW, Galan HL, Harper L, Omurtag K, Muffly TM, Sheeder J, Guntupalli SR.

J Surg Educ. 2019 Jan - Feb;76(1):93-98. doi: 10.1016/j.jsurg.2018.06.013. Epub 2018 Aug 7.

PMID:
30093331
10.

Combined symptom index and second-generation multivariate biomarker test for prediction of ovarian cancer in patients with an adnexal mass.

Urban RR, Pappas TC, Bullock RG, Munroe DG, Bonato V, Agnew K, Goff BA.

Gynecol Oncol. 2018 Aug;150(2):318-323. doi: 10.1016/j.ygyno.2018.06.004. Epub 2018 Jun 19.

PMID:
29929922
11.

Opioid use in gynecologic oncology in the age of the opioid epidemic: Part II - Balancing safety & accessibility.

Ramzan AA, Fischer S, Buss MK, Urban RR, Patsner B, Duska LR, Fisher CM, Lefkowits C.

Gynecol Oncol. 2018 May;149(2):401-409. doi: 10.1016/j.ygyno.2018.02.008. Epub 2018 Mar 12. Review.

PMID:
29544707
12.

Opioid use in gynecologic oncology in the age of the opioid epidemic: Part I - Effective opioid use across clinical settings, a society of gynecologic oncology evidence-based review.

Lefkowits C, Buss MK, Ramzan AA, Fischer S, Urban RR, Fisher CM, Duska LR.

Gynecol Oncol. 2018 May;149(2):394-400. doi: 10.1016/j.ygyno.2018.01.027. Epub 2018 Feb 20. Review.

PMID:
29472016
13.

Robotic, Laparoscopic, or Open Hysterectomy: Surgical Outcomes by Approach in Endometrial Cancer.

Beck TL, Schiff MA, Goff BA, Urban RR.

J Minim Invasive Gynecol. 2018 Sep - Oct;25(6):986-993. doi: 10.1016/j.jmig.2018.01.010. Epub 2018 Jan 31.

PMID:
29360514
14.

Fellow perceptions of residency training in obstetricsĀ and gynecology.

Urban RR, Ramzan AA, Doo DW, Galan HL, Harper L, Omurtag K, Muffly TM, Sheeder J, Guntupalli SR.

Am J Obstet Gynecol. 2018 Apr;218(4):461-462. doi: 10.1016/j.ajog.2018.01.021. Epub 2018 Jan 17. No abstract available.

PMID:
29353035
15.

The end of life costs for Medicare patients with advanced ovarian cancer.

Urban RR, He H, Alfonso R, Hardesty MM, Goff BA.

Gynecol Oncol. 2018 Feb;148(2):336-341. doi: 10.1016/j.ygyno.2017.11.022. Epub 2017 Dec 6.

PMID:
29208368
16.

Combining a symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass.

Goff BA, Agnew K, Neradilek MB, Gray HJ, Liao JB, Urban RR.

Gynecol Oncol. 2017 Nov;147(2):291-295. doi: 10.1016/j.ygyno.2017.08.020. Epub 2017 Aug 30.

PMID:
28860006
17.

Racial disparities in the utilization of preventive health services among older women with early-stage endometrial cancer enrolled in Medicare.

Martin JY, Schiff MA, Weiss NS, Urban RR.

Cancer Med. 2017 Sep;6(9):2153-2163. doi: 10.1002/cam4.1141. Epub 2017 Aug 4.

18.

Strategies for Introducing Outpatient Specialty Palliative Care in Gynecologic Oncology.

Hay CM, Lefkowits C, Crowley-Matoka M, Bakitas MA, Clark LH, Duska LR, Urban RR, Creasy SL, Schenker Y.

J Oncol Pract. 2017 Sep;13(9):e712-e720. doi: 10.1200/JOP.2017.020818. Epub 2017 Aug 1.

19.

Metastases from lung adenocarcinoma within a leiomyoma: A case report.

Rush SK, Toukatly MN, Kilgore MR, Urban RR.

Gynecol Oncol Rep. 2017 Feb 6;20:27-29. doi: 10.1016/j.gore.2017.02.001. eCollection 2017 May.

20.

Gynecologic Oncologist Views Influencing Referral to Outpatient Specialty Palliative Care.

Hay CM, Lefkowits C, Crowley-Matoka M, Bakitas MA, Clark LH, Duska LR, Urban RR, Chen LM, Creasy SL, Schenker Y.

Int J Gynecol Cancer. 2017 Mar;27(3):588-596. doi: 10.1097/IGC.0000000000000893.

21.

Physicians' Perspectives and Practice Patterns Toward Opportunistic Salpingectomy in High- and Low-Risk Women.

Jones NL, Schulkin J, Urban RR, Wright JD, Burke WM, Hou JY, McElwain CA, Tergas AI.

Cancer Invest. 2017 Jan 2;35(1):51-61. doi: 10.1080/07357907.2016.1242597. Epub 2016 Dec 28.

PMID:
28029807
22.

Evaluation of a Validated Biomarker Test in Combination With a Symptom Index to Predict Ovarian Malignancy.

Urban RR, Smith A, Agnew K, Bonato V, Goff BA.

Int J Gynecol Cancer. 2017 Feb;27(2):233-238. doi: 10.1097/IGC.0000000000000873.

PMID:
27870706
23.

Routine proteinuria monitoring for bevacizumab in patients with gynecologic malignancies.

Lee CS, Alwan LM, Sun X, McLean KA, Urban RR.

J Oncol Pharm Pract. 2016 Dec;22(6):771-776. Epub 2015 Oct 6.

PMID:
26447100
24.

Neoplastic cellularity is associated with clinical and molecular features of high-grade serous ovarian carcinoma.

Morse CB, Norquist BM, Harrell MI, Agnew KJ, Gray HJ, Urban RR, Garcia RL, Goff BA, Swisher EM.

Gynecol Oncol. 2016 Nov;143(2):389-392. doi: 10.1016/j.ygyno.2016.08.324. Epub 2016 Aug 27.

PMID:
27575909
25.

Implementing the "Flipped Classroom" on a Gynecologic Oncology Service.

Urban RR, Swensen RE, Schulkin J, Schiff MA.

J Reprod Med. 2016 Sep;61(9-10):405-410.

PMID:
30383935
26.

Preoperative hyponatremia in women with ovarian cancer: An additional cause for concern?

Martin JY, Goff BA, Urban RR.

Gynecol Oncol. 2016 Sep;142(3):471-6. doi: 10.1016/j.ygyno.2016.06.018. Epub 2016 Jul 4.

27.

Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers.

Martin JY, Urban RR, Liao JB, Goff BA.

J Gynecol Oncol. 2016 Sep;27(5):e47. doi: 10.3802/jgo.2016.27.e47. Epub 2016 May 10.

28.

The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer.

Urban RR, He H, Alfonso-Cristancho R, Hardesty MM, Goff BA.

J Natl Compr Canc Netw. 2016 Apr;14(4):429-37.

PMID:
27059191
29.

Ovarian cancer outcomes: Predictors of early death.

Urban RR, He H, Alfonso R, Hardesty MM, Gray HJ, Goff BA.

Gynecol Oncol. 2016 Mar;140(3):474-80. doi: 10.1016/j.ygyno.2015.12.021. Epub 2015 Dec 29.

PMID:
26743531
30.

Route of hysterectomy and surgical outcomes from a statewide gynecologic oncology population: is there a role for vaginal hysterectomy?

Beck TL, Morse CB, Gray HJ, Goff BA, Urban RR, Liao JB.

Am J Obstet Gynecol. 2016 Mar;214(3):348.e1-9. doi: 10.1016/j.ajog.2015.10.006. Epub 2015 Oct 22.

PMID:
26470825
31.

Comprehensive care in gynecologic oncology: The importance of palliative care.

Landrum LM, Blank S, Chen LM, Duska L, Bae-Jump V, Lee PS, Levine L, McCourt C, Moore KN, Urban RR.

Gynecol Oncol. 2015 May;137(2):193-202. doi: 10.1016/j.ygyno.2015.02.026. Epub 2015 Mar 4. No abstract available.

PMID:
25749723
32.

Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States.

Fuh KC, Shin JY, Kapp DS, Brooks RA, Ueda S, Urban RR, Chen LM, Chan JK.

Gynecol Oncol. 2015 Mar;136(3):491-7. doi: 10.1016/j.ygyno.2014.10.009. Epub 2014 Oct 16.

PMID:
25455734
34.

Predictors of intensive care unit utilization in gynecologic oncology surgery.

Ruskin R, Urban RR, Sherman AE, Chen LL, Powell CB, Burkhardt DH 3rd, Chen LM.

Int J Gynecol Cancer. 2011 Nov;21(8):1336-42. doi: 10.1097/IGC.0b013e31822d0ed0.

PMID:
21897266
35.

Gynecologic malignancies in female-to-male transgender patients: the need of original gender surveillance.

Urban RR, Teng NN, Kapp DS.

Am J Obstet Gynecol. 2011 May;204(5):e9-e12. doi: 10.1016/j.ajog.2010.12.057. Epub 2011 Feb 26.

PMID:
21354550
36.

In vivo evidence for increased adrenal sensitivity to adrenocorticotropin-(1-24) in the lamb fetus late in gestation.

Rose JC, Meis PJ, Urban RR, Greiss FC Jr.

Endocrinology. 1982 Jul;111(1):80-5.

PMID:
6282574

Supplemental Content

Loading ...
Support Center